Stay updated on Clinical Trial: Benfotiamine in Alzheimer's Disease
Sign up to get notified when there's something new on the Clinical Trial: Benfotiamine in Alzheimer's Disease page.

Latest updates to the Clinical Trial: Benfotiamine in Alzheimer's Disease page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe page revision/version label was updated from v3.5.2 to v3.5.3, with no visible change to the study’s substantive content.SummaryDifference0.1%

- Check19 days agoChange DetectedAdded Revision: v3.5.2 and removed Revision: v3.5.0.SummaryDifference0.1%

- Check26 days agoNo Change Detected
- Check47 days agoChange DetectedRevision: v3.5.0 added and v3.4.3 removed.SummaryDifference0.1%

- Check54 days agoChange DetectedUpdated the page revision from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check83 days agoChange DetectedA new link to the Genetic and Rare Diseases Information Center was added under Resources and 'Amyloidosis' was added as a keyword, while the page revision updated from v3.4.1 to v3.4.2.SummaryDifference0.2%

- Check90 days agoChange DetectedRevision: v3.4.1 replaces the previous v3.4.0 on the page. The update appears to be a minor backend/markup revision without changes to study details or user-visible content.SummaryDifference0.1%

Stay in the know with updates to Clinical Trial: Benfotiamine in Alzheimer's Disease
Enter your email address, and we'll notify you when there's something new on the Clinical Trial: Benfotiamine in Alzheimer's Disease page.